Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01446731
Recruitment Status : Completed
First Posted : October 5, 2011
Last Update Posted : August 16, 2016
Information provided by (Responsible Party):
Inge Marie Svane, Herlev Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015